Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT: Avastin and Chemotherapy followed by Avastin alone or Avastin + Tarceva in metastatic colorectal cancer
2006-002295-18Phase 3Completed
- Sponsor
- University Hospital, Dept of Oncology, clinical trial unit
- Start
- Dec 2006
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in colorectal cancer (CRC) comparing Bevacizumab + erlotinib maintenance with Bevacizumab maintenance (2 arms). Primary endpoint: Progression-free survival. Started Dec 2006; status: completed.
02
Drugs
bevacizumaberlotinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2006-002295-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002295-18.